Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma

Background. Angiotensin-(1-7) [Ang-(1-7)] is an endogenous antiangiogenic hormone with anticancer activity. In a phase I study of Ang-(1-7), two of three patients with metastatic sarcoma experienced disease stabilization. This phase II study examined clinical and biomarker outcomes for patients with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sarcoma
Egile Nagusiak: Savage, Paul D., Lovato, James, Brosnihan, K. Bridget, Miller, Antonius A., Petty, W. Jeffrey
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2016
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118533/
https://ncbi.nlm.nih.gov/pubmed/27895527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4592768
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak